Regeneron Pharmaceuticals
REGN
#215
Rank
โ‚น7.077 T
Marketcap
โ‚น64,406
Share price
-2.48%
Change (1 day)
-2.21%
Change (1 year)

Revenue for Regeneron Pharmaceuticals (REGN)

Revenue in 2024 (TTM): โ‚น1.155 Trillion

According to Regeneron Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น1.168 Trillion. In 2023 the company made a revenue of โ‚น1.091 Trillion an increase over the revenue in the year 2022 that were of โ‚น1.007 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regeneron Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น1.155 T5.8%
2023 โ‚น1.091 T8.41%
2022 โ‚น1.007 T-15.79%
2021 โ‚น1.196 T92.5%
2020 โ‚น621.42 B26.96%
2019 โ‚น489.45 B4.31%
2018 โ‚น469.23 B25.15%
2017 โ‚น374.94 B13.52%
2016 โ‚น330.28 B21.11%
2015 โ‚น272.71 B52.61%
2014 โ‚น178.69 B37.43%
2013 โ‚น130.03 B72.28%
2012 โ‚น75.47 B220.03%
2011 โ‚น23.58 B14.65%
2010 โ‚น20.57 B16.89%
2009 โ‚น17.59 B53.54%
2008 โ‚น11.46 B133.59%
2007 โ‚น4.90 B74.61%
2006 โ‚น2.81 B-5.66%
2005 โ‚น2.97 B-60.48%
2004 โ‚น7.53 B186.83%
2003 โ‚น2.62 B149.18%
2002 โ‚น1.05 B-0.55%
2001 โ‚น1.06 B-61.8%
2000 โ‚น2.77 B85.04%
1999 โ‚น1.49 B-7.66%
1998 โ‚น1.62 B24.86%
1997 โ‚น1.30 B50.14%
1996 โ‚น0.86 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น2.745 T 134.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น176.79 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น816.28 B-30.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.401 T 533.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.214 T 260.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น4.515 T 286.41%๐Ÿ‡ซ๐Ÿ‡ท France